| HOME >> BIOLOGY >> TECHNOLOGY |
Eli Lilly Acquires ImClone Systems II-57
Antisoma Acquires Xanthus II-58
Cellzome and GSK to Jointly Develop Kinase Inhibitors II-58
Deciphera Pharmaceuticals Partners with Eli Lilly in Oncology Therapy II-58
ACT Biotech Agrees to Acquire the Under Clinical Stage
Oncology Portfolio of Bayer Healthcare II-59
Cancer Research UK Enters into Clinical Development Agreement with AstraZeneca II-59
Daiichi and ArQule Enter into Product Development Agreement II-59
Cellzome and GlaxoSmithKline Form Alliance II-60
Emiliem Enters into Agreement with NIH II-60
Astex and Janssen Pharmaceutica Form Alliance II-60
Millipore Launches Tyrosine Kinases Integrated with BioForm Technology II-60
Aegera Therapeutics Takes over LymphoSign II-61
ARIAD and Merck Collaborate on AP23573 II-61
Invitrogen Form Partnership with Emiliem II-61
Pfizer Collaborate with Rigel, to Develop R343 as Treatment for Allergic AsthmaII-62
6. FOCUS ON SELECT PLAYERS II-63
Amgen, Inc. (US) II-63
Asahi Kasei Pharma Corporation (Japan) II-63
AstraZeneca plc (UK)II-63
Bayer Schering Pharma AG (Germany) II-63
Bristol-Myers Squibb Company (US) II-64
Celgene Corporation (US) II-64
Exelixis, Inc. (US) II-64
F. Hoffmann-La Roche, Ltd. (Switzerland) II-65
Chugai Pharmaceutical Co, Ltd. (Japan) II-65
Genentech, Inc. (US) II-65
GlaxoSmithKline plc (UK) II-65
KAI Pharmaceuticals, Inc (USA) II-66
Merck & Co., Inc (USA) II-66
Mitsubishi Tanabe Pharma Corporation (Japan) II-67
Novartis International AG (Switzerland) II-67
Onyx Pharmaceuticals, Inc. (US) II-67
OSI Pharmaceuticals, Inc. (US) II-67
Pfizer, Inc. (US) II-68
Takeda Pharmaceutical Company Limited (Japan) II-68
Millennium Pharmaceuticals Inc (USA
'/>"/>
| SOURCE Reportlinker Copyright©2009 PR Newswire. All rights reserved |